Celgene Corporation - Contingent Value Right (CELGZ)

0.49
0.00 0.02
NASDAQ
Prev Close 0.49
Open 0.48
Day Low/High 0.48 / 0.49
52 Wk Low/High 0.35 / 2.65
Volume 3.58K
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

Celgene: Abraxane Boosts Pancreatic Cancer Survival

Celgene: Abraxane Boosts Pancreatic Cancer Survival

Expanding use of Abraxane into pancreatic cancer could net Celgene another $1 billion in revenue.

Celgene Surprises With Melanoma Drug Study Victory

Celgene Surprises With Melanoma Drug Study Victory

Celgene's Abraxane delays tumor growth in patients with advanced melanoma.

Celgene's Abraxane Is Talk of European Cancer Confab

Celgene's Abraxane Is Talk of European Cancer Confab

A study of Abraxane in pancreatic cancer generates a ton of buzz even with data still weeks away.

Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data

Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data

How best to invest in the next important clinical trial catalyst facing Celgene.